AMYT.L Gross Margin

As of 2025-05-22, the Gross Margin of Amryt Pharma PLC (AMYT.L) is 3481.7%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

AMYT.L Gross Margin - Historical Value

Date	Value
2020-12-31	3481.7%
2019-12-31	33.4%
2018-12-31	63.3%
2017-12-31	58%
2016-12-31	56.6%
2015-12-31	-
2015-03-31	-
2014-03-31	-
2013-03-31	-
2012-03-31	-

AMYT.L Gross Margin - Peers Comparison

Ticker	Name	Value
ACPH.BR	Acacia Pharma Group PLC	74.6%
ADVIC.PA	Advicenne SA	-49723.6%
AGY.L	Allergy Therapeutics PLC	53.9%
CALTX.ST	Calliditas Therapeutics AB	95%
CLBIO.ST	Corline Biomedical AB	137.5%
CLN.WA	Celon Pharma SA	69.2%
EAH.L	ECO Animal Health Group PLC	42.1%
ENZY.ST	Enzymatica AB (publ)	67.4%
ERMA.ST	Enorama Pharma AB	23.5%
FCM.MI	Friulchem SpA	18%
HYL.BR	Hyloris Pharmaceuticals SA	70.9%
IBT B.ST	Infant Bacterial Therapeutics AB	7775.2%
INDEX.ST	InDex Pharmaceuticals Holding AB	-82%
IRLAB A.ST	IRLAB Therapeutics AB	-44%
KDEV.ST	Karolinska Development AB	-350.1%
LAVI.AT	Lavipharm SA	47.4%
LIPI.ST	Lipidor AB	-82.3%
MARI.VI	Marinomed Biotech AG	12.5%
MOB.ST	Moberg Pharma AB (publ)	64.4%
NUTEX.BD	Nutex Befektetesi Nyrt	100%
OAT.WA	Oncoarendi Therapeutics SA	-26049.8%
ORX.ST	Orexo AB	87.8%
OVB.L	Ovoca Bio PLC	7775.2%
PHO.OL	Photocure ASA	94.2%
PRL.MI	Pierrel SpA	70.2%
RLS.ST	RLS Global AB	-34.3%
SHE.MI	Shedir Pharma Srl Unipersonale	60.3%
VISTN.OL	Vistin Pharma ASA	65.1%